| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.38 | 3e-09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.24 | 7e-09 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.31 | 3e-08 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.37 | 1e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.29 | 4e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.24 | 6e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-06 |